AUG 24, 2021 5:00 AM PDT

A New Chapter in Metastatic Breast Cancer Biomarkers

WRITTEN BY: Tara Fernandez

For patients diagnosed with metastatic breast cancer, it’s often not the primary tumor that has fatal consequences, but metastases that have taken hold in essential organs such as the lungs and the brain. 

Ultimately, the ability to spot the signs of metastasis early has immense life-saving potential for these patients—responding quickly with intensive therapeutic interventions could prevent cancerous cells from breaking off and spreading away from malignant breast tissue.

In a breakthrough study, a team of cancer researchers from Tel Aviv University profiled the genetic makeup of cancer cells, revealing never-before-seen gene signatures that represent novel metastatic breast cancer biomarkers.

The scientists were interested in one particular cell type known to be a central player in breast cancer metastases: Cancer-associated fibroblasts. These cells are typically found in the peripheral regions of solid breast tumors. Until now, however, how these fibroblasts influence the journey of cancer cells to distant sites away from the primary tumor has remained a black box. 

In the study, the team used a specialized mouse model, genetically engineered to allow the researchers to watch, track, and profile cancer-associated fibroblasts in spontaneous lung metastasis. 

Interestingly, by generating full genetic profiles of these metastatic cells alongside those from healthy lung tissues, the investigators were able to draw out distinct gene expression profiles associated with early and late metastatic disease. These important findings shed light on how cancer cells grow and the subtle changes occurring in the tumor microenvironment at every stage of metastasis.

Most critically, these profiles can be used as diagnostic reference points to gain insights on the nature of breast tumor biopsies taken from cancer patients. Patients most at risk of cancer progression can undergo more aggressive interventions to slow—or ideally, completely block—breast cancer metastasis.

Speaking on the significance of this future clinical application, lead researcher Neta Erez said: “Understanding the body’s preparation for the reception of metastases at an early stage may save millions of lives.”

 


Source: eLife, Tel Aviv University News.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 15, 2021
Clinical & Molecular DX
Childhood Lead Exposure Influences Personality in Adulthood
JUL 15, 2021
Childhood Lead Exposure Influences Personality in Adulthood
Exposure to toxic chemicals in childhood could have unlikely effects on personality, and behavioral traits in adulthood, ...
JUL 29, 2021
Genetics & Genomics
Obesity May Not Always Lead to Disease
JUL 29, 2021
Obesity May Not Always Lead to Disease
Some gene variants might be protecting people from the negative health effects of obesity.
AUG 29, 2021
Cancer
Blood Test over 90% Accurate in Detecting Lung Cancer
AUG 29, 2021
Blood Test over 90% Accurate in Detecting Lung Cancer
An AI-powered blood test was able to correctly detect the presence of lung cancer over 90% of the time in patient sample ...
SEP 09, 2021
Clinical & Molecular DX
A Drug Test for Synthetic Cannabis Use
SEP 09, 2021
A Drug Test for Synthetic Cannabis Use
Designer drugs are synthetic analogs of prohibited substances such as cocaine and LSD made in clandestine laboratories a ...
OCT 07, 2021
Clinical & Molecular DX
Computational Crystal Ball Predicts Which COVID Variants Are More Dangerous
OCT 07, 2021
Computational Crystal Ball Predicts Which COVID Variants Are More Dangerous
Viruses are natures shapeshifters; their genomes are in a constant state of flux as they divide in their hosts. Over tim ...
NOV 04, 2021
Clinical & Molecular DX
Tech Offers a Brighter Tomorrow for Difficult-To-Treat Epilepsy Patients
NOV 04, 2021
Tech Offers a Brighter Tomorrow for Difficult-To-Treat Epilepsy Patients
It's difficult for neurologists to predict which patients living with epilepsy will respond to anti-seizure medicine ...
Loading Comments...